Skip to main content

Table 1 Selection of agonist and antagonist docking structures.

From: Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists

Structure Resolution (Å) Mutation/Modified residues Bound ligand
1GWR (agonist) 2.4 - Estradiol
3ERT (antagonist) 1.9 - 4-hydroxytamoxifen
  1. Crystal structures selected from the PDB to be targets for the agonist and antagonist docking and the associated details.